The DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions
Open accessAbstract
After publication of the updated World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues in 2008, the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph) now presents an update of the hierarchical classification of lymphoid neoplasms for epidemiologic research based on the 2001 WHO classification, which we published in 2007. The updated hierarchical classification incorporates all of the major and provisional entities in the 2008 WHO classification, including newly defined entities based on age, site, certain infections, and molecular characteristics, as well as borderline categories, early and “in situ” lesions, disorders with limited capacity for clinical progression, lesions without current International Classification of Diseases for Oncology, 3rd Edition codes, and immunodeficiency-associated lymphoproliferative disorders. WHO subtypes are defined in hierarchical groupings, with newly defined groups for small B-cell lymphomas with plasmacytic differentiation and for primary cutaneous T-cell lymphomas. We suggest approaches for applying the hierarchical classification in various epidemiologic settings, including strategies for dealing with multiple coexisting lymphoma subtypes in one patient, and cases with incomplete pathologic information. The pathology materials useful for state-of-the-art epidemiology studies are also discussed. We encourage epidemiologists to adopt the updated InterLymph hierarchical classification, which incorporates the most recent WHO entities while demonstrating their relationship to older classifications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“North American registries define multiple primary cancers under the rules of the Surveillance Epidemiology and End Results (SEER) programme.22 Those rules accept more cancers as new primary cancers than the rules of the International Association of Cancer Registries (IACR),23 which are used by most cancer registries in other continents.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationEgner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 6,011
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,950
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,614
Hans, C. P. (2003) · Blood · doi:10.1182/blood-2003-05-1545 · Cited by 4,270
Rosenwald, A., Wright, G. W., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Müller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,832
Self-citationA review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Research works printed but not linked: 3
- Percy, 2001, Conversion of neoplasms by topography and morphology from the International Classification of Diseases for Oncology, second edition, to International Classification of Diseases for Oncology
- Horner, SEER Cancer Statistics Review, 1975-2006, National Cancer Institute.
- Johnson, 2010, Hematopoietic and Lymphoid Neoplasm Case Reportability and Coding Manual
Cited by
Sorted by citations
Items 101–200 of 231
Morimoto, Y., Conroy, S. M., Ollberding, N. J., Henning, S. M., Franke, A. A., Wilkens, L. R., Goodman, M. T., Hernandez, B. Y., Marchand, L. L., Henderson, B. E., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0048-1 · Cited by 25
“NHL cases were classified according to the International Classification of Diseases for Oncology, Third Edition (ICD-O-3) and aggregated into subtypes in accordance with the proposed hierarchical classification of lymphoid neoplasms for epidemiologic research [20].”
MethodGibson, T. M., Smedby, K. E. E., Skibola, C. F., Hein, D. W., Slager, S. L., de Sanjosé, S., Vajdic, C. M., Zhang, Y., Chiu, B. C. ‐., Wang, S., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0098-4 · Cited by 24
“Organization (WHO) classification [24] using InterLymph Pathology Working Group guidelines [25].”
MethodSelf-citationDietary fat intake and risk of non-Hodgkin lymphoma in 2 large prospective cohorts
Bertrand, K. A., Giovannucci, E. L., ROSNER, B. A., Zhang, S. M., Laden, F., & Birmann, B. M. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.155010 · Cited by 24
Ionising radiation as a risk factor for lymphoma: a review
Harbron, R. W., & Pasqual, E. (2020) · Journal of Radiological Protection · doi:10.1088/1361-6498/abbe37 · Cited by 26
“As mentioned in the introduction, CLL and MM are regarded as subtypes of NHL [1], but are almost always analysed separately and will be reported as described in the cited papers.”
BackgroundInfluentialOlszewski, A. J., Winer, E. S., & Castillo, J. J. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0610-8 · Cited by 24
“We selected DLBCL patients diagnosed between 2004 and 2011 using histology codes according to the InterLymph classification of lymphomas for epidemiologic research [13].”
MethodGlaser, S. L., Clarke, C. A., Keegan, T. H. M., Chang, E. T., & Weisenburger, D. D. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0281 · Cited by 24
“Its categories are captured by International Classification of Diseases for Oncology (ICD-O) codes, with which tumor registrars code Hodgkin lymphoma histologic subtypes based on pathology reports (5).”
BackgroundSelf-citationAya‐Bonilla, C., Green, M. R., Camilleri, E. T., Benton, M. C., Keane, C., Marlton, P. V., Lea, R. A., Gandhi, M. K., & Griffiths, L. R. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22044 · Cited by 25
“ogeneous group of lymphoid-derived hematological neoplasms (Swerdlow et al., 2008; Turner et al., 2010).”
BackgroundGeris, J. M., Spector, L. G., Pfeiffer, R. M., Limaye, A. P., Yu, K. J., & Engels, E. A. (2022) · Cancer · doi:10.1002/cncr.34462 · Cited by 21
“Lymphoma subtypes were classified according to current International Lymphoma Epidemiology Consortium guidelines.(24) We analyzed cancer sites with at least 60 cases among transplant recipients.”
MethodReproductive factors and lymphoid neoplasms in Europe: findings from the EpiLymph case–control study
Costas, L., Casabonne, D., Benavente, Y., Becker, N., Boffetta, P., Brennan, P., Cocco, P., Foretová, L., Maynadié, M., Staines, A. S., et al. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9869-6 · Cited by 23
“Cases were categorized according to the most recent World Health Organization (WHO, 2008) Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues and the International Lymphoma Epidemiology Consortium (InterLymph) guidelines [24, 25].”
MethodSelf-citationTwo high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
McMaster, M. L., Berndt, S. I., Zhang, J., Slager, S. L., Li, S. A., Vajdic, C. M., Smedby, K. E. E., Yan, H., Birmann, B. M., Brown, E. E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06541-2 · Cited by 23
Self-citationOccupational exposure to endocrine disruptors and lymphoma risk in a multi-centric European study
Costas, L., Infante‐Rivard, C., Zock, J.-P., van Tongeren, M., Boffetta, P., Cusson, A., Robles, C., Casabonne, D., Benavente, Y., Becker, N., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.83 · Cited by 22
“Cases were coded with ICD-O-3, and were classified according to the most recent World Health Organization (WHO) Classification (Swerdlow, 2008; Turner et al, 2010).”
BackgroundMethodSelf-citationDellaValle, C. T., Deziel, N. C., Jones, R. R., Colt, J. S., Roos, A. J. D., Cerhan, J. R., Cozen, W., Severson, R. K., Flory, A., Morton, L. M., et al. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0660-y · Cited by 22
“We conducted separate and multinomial logistic regression analyses for NHL subtypes for which we had sufficient cases (n C 25), grouped according to the World Health Organization classification [33, 34] using the InterLymph consortium guidelines [35, 36].”
MethodSelf-citationHester, L., Park, S. I., Wood, W. A., Stürmer, T., Brookhart, M. A., & Lund, J. L. (2018) · Cancer · doi:10.1002/cncr.31821 · Cited by 22
Zhong, C., Franklin, M., Wiemels, J. L., McKean‐Cowdin, R., Chung, N. T., Benbow, J. L., WANG, S. S., Lacey, J. V., & Longcore, T. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101811 · Cited by 22
Epidemiology of Hematologic Malignancies
Batista, J. L., Birmann, B. M., & Epstein, M. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_29 · Cited by 21
“uniformity in the investigation of lymphoma subtypes in epidemiologic research [11, 12].”
BackgroundCohort profile: four early uranium processing facilities in the US and Canada
Golden, A. P., Milder, C. M., Ellis, E. D., Anderson, J. L., Boice, J. D., Bertke, S. J., & Zablotska, L. B. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2021.1917786 · Cited by 20
“2021) while experimental data indicate that chemically toxic soluble uranium compounds could potentially impair kidney function, as has been shown in high dose laboratory animal studies (UNSCEAR 2011; ATSDR 2013), while lower dose studies indicated only transient changes (Turner et al. 2010).”
ResultMorton, L. M., Curtis, R. E., Linet, M. S., Schonfeld, S. J., Advani, P. G., Dalal, N., Sasse, E. C., & Dores, G. M. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102060 · Cited by 20
Self-citationNaudin, S., Solans, M., Hosnijeh, F. S., Nieters, A., Kyrø, C., Tjønneland, A. M., Dahm, C. C., Overvad, K., Mahamat‐Saleh, Y., Besson, C., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32977 · Cited by 19
Hosnijeh, F. S., Casabonne, D., Nieters, A., Solans, M., Naudin, S., Ferrari, P., McKay, J., Benavente, Y., Weiderpass, E., Freisling, H., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33369 · Cited by 18
“Immunodeficiency and autoimmunity are strong B-cell lymphoma risk factors.(1)”
BackgroundMethodInfluentialYin, Q., Lin, C., Li, Q., Mi, R., Li, Y., Wei, X., & Song, Y. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0085-9 · Cited by 19
Skibola, C. F., Slager, S. L., Berndt, S. I., Lightfoot, T., Sampson, J. N., Morton, L. M., & Weisenburger, D. D. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu009 · Cited by 19
“Cases were classified according to the World Health Organization classification (15,16) using guidelines from the InterLymph Pathology Working Group (17,18).”
MethodSelf-citationChiu, Y., Bertrand, K. A., Zhang, S., Laden, F., Epstein, M. M., ROSNER, B. A., Chiuve, S. E., Campos, H., Giovannucci, E. L., Chavarro, J. E., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31602 · Cited by 18
Cancer risk following lymphoid malignancies among HIV-infected people
Mahale, P. S., Ugoji, C. C., Engels, E. A., Shiels, M. S., Peprah, S., & Morton, L. M. (2020) · AIDS · doi:10.1097/qad.0000000000002528 · Cited by 19
“International Classification of Diseases for Oncology, version 3 (ICD-O-3) morphology codes and the InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification [7].”
MethodSelf-citationOllberding, N. J., Maskarinec, G., Conroy, S. M., Morimoto, Y., Franke, A. A., Cooney, R. V., Wilkens, L. R., Marchand, L. L., Goodman, M. T., Hernandez, B. Y., et al. (2012) · Blood · doi:10.1182/blood-2012-02-413609 · Cited by 18
Lymphoma risk in livestock farmers: Results of the Epilymph study
Cocco, P., Satta, G., D’Andrea, I., Nonne, T., Udas, G., Zucca, M., Mannetje, A. ’., Becker, N., de Sanjosé, S., Foretová, L., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27908 · Cited by 18
“For the purposes of the epidemiological analysis, the diagnoses were subsequently grouped according to the protocol of the InterLymph Consortium.(18) Controls from Germany and Italy were randomly selected by sampling from the general population, while the rest of the centers used matched hospital controls, with eligib…”
MethodSelf-citationParental Age at Birth and Risk of Hematological Malignancies in Older Adults
Teras, L. R., Gaudet, M. M., Blase, J. L., & Gapstur, S. M. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwu487 · Cited by 18
Olszewski, A. J., Shafqat, H., & Ali, S. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.936013 · Cited by 17
Lymphoma and multiple myeloma in cohorts of persons exposed to ionising radiation at a young age
Little, M. P., Wakeford, R., Zablotska, L. B., Borrego, D., Griffin, K., Allodji, R. S., de Vathaire, F., Lee, C., Brenner, A. V., Miller, J. S., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01284-4 · Cited by 17
“Owing to the large temporal range in the data and the notable changes in lymphoma classification during the past 60+ years 35–37 , we had to concentrate on large subtype groups, and could not include more recent subtype classifications.”
Self-citationEpstein, M. M., ROSNER, B. A., Breen, E. C., Batista, J. L., Giovannucci, E. L., Magpantay, L. I., Aster, J. C., Rodig, S. J., Bertrand, K. A., Laden, F., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.183236 · Cited by 17
“Study pathologists (JCA, SJR) classified NHL histological subtype(19) according to World Health Organization(20,21) and International Lymphoma Epidemiology (InterLymph) Consortium guidelines.(22,23) We analyzed common B-cell (B-)NHL subtypes individually [diffuse large”
MethodHematologic malignancies of the gastrointestinal luminal tract
Hanafy, A. K., Morani, A. C., Menias, C. O., Pickhardt, P. J., Shaaban, A. M., Mujtaba, B., Mellnick, V. M., & Elsayes, K. M. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02278-8 · Cited by 16
Alfano, M., Locatelli, I., D’Arrigo, C., Mora, M., Vozzi, G., Acutis, A. D., Pece, R., Tavella, S., Costa, D., Poggi, A. D., et al. (2022) · Cancers · doi:10.3390/cancers14010259 · Cited by 17
“FL stages were according to the 2008 WHO classification [28].”
MethodDiver, W. R., Teras, L. R., Deubler, E. L., & Turner, M. C. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02718-3 · Cited by 16
Solans, M., Benavente, Y., Sáez, M., Agudo, A., Naudin, S., Hosnijeh, F. S., Noh, H., Freisling, H., Ferrari, P., Besson, C., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32091 · Cited by 16
Solans, M., Romaguera, D., Gràcia‐Lavedan, E., Molinuevo, A., Benavente, Y., Sáez, M., Marcos‐Gragera, R., Costas, L., Robles, C., Alonso, E., et al. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2019.101629 · Cited by 16
Self-citationTo Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes
Koff, J. L., Chihara, D., Phan, A., Nastoupil, L. J., Williams, J. N., & Flowers, C. R. (2015) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-015-0267-0 · Cited by 15
Exposure to Environmental Tobacco Smoke and Risk of Non-Hodgkin Lymphoma in Nonsmoking Men and Women
Diver, W. R., Teras, L. R., Gaudet, M. M., & Gapstur, S. M. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu016 · Cited by 15
“Histological subtypes were defined using the InterLymph PathologyWorking Group guidelines (12), based on the 2008 revised World Health Organization classification of tumors of hematopoietic and lymphoid tissues (13).”
MethodPeyman, G. A., May, D. R., Ericson, E. S., & Goldberg, M. F. (1972) · PubMed · Cited by 15
Trends in excess mortality in follicular lymphoma at a population level
Mounier, M., Bossard, N., Belot, A., Remontet, L., Iwaz, J., Dandoit, M., Girard‐Boulanger, S., Herry, A., Woronoff, A., Casasnovas, O., et al. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12403 · Cited by 14
“The diagnosis of FL was defined according to the third edition of the International Classification of Diseases for Oncology (ICD-O-3), that is, using morphology code 9690/3 for follicular lymphoma NOS, 9691/3 for follicular lymphoma grade 2, 9695/3 for follicular lymphoma grade 1 and 9698/3 for follicular lymphoma gra…”
Self-citationMalaria and risk of lymphoid neoplasms and other cancer: a nationwide population-based cohort study
Wyss, K., Granath, F. N., Wångdahl, A., Djärv, T., Fored, M., Nauclér, P., & Färnert, A. (2020) · BMC Medicine · doi:10.1186/s12916-020-01759-8 · Cited by 14
“Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P, Stagnaro E, Willett EV, Franceschi S, La Vecchia C, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph).”
MethodInfluentialMigdady, Y., Salhab, M., Dang, N. H., Markham, M. J., & Olszewski, A. J. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1102246 · Cited by 14
“Using the 2008 WHO classification [2], we extracted data on the six common NHL subtypes, spanning the range from highly aggressive to indolent histologies: DLBCL, Burkitt’s lymphoma (BL), peripheral T-cell lymphoma (PTCL), mantle cell lymphoma (MCL), follicular lymphoma (FL), and CLL/small lymphocytic lymphoma (CLL/SL…”
BackgroundMethodEbied, A., Huan, V. T., Makram, O. M., Sang, T. K., Ghorab, M. M. E., Ngo, H. T., Iraqi, A., Kamel, M. G., Đăng, T. N., Vuong, N. L., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1280 · Cited by 14
“HL cases were defined in the SEER database according to the third edition of the International Classification of Diseases for Oncology (ICDO3) coding system and in compliance with the InterLymph Consortium classification of lymphoid neoplasms for epidemiological research based on the 2008 WHO classification [12, 13].”
MethodLeo, Q. J. N., Ollberding, N. J., Wilkens, L. R., Kolonel, L. N., Henderson, B. E., Marchand, L. L., & Maskarinec, G. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.139 · Cited by 14
Ali, S., & Olszewski, A. J. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.847938 · Cited by 13
Madsen, C., Clausen, M. R., Plesner, T., Pasanen, A., Kuismanen, T., Bentzen, H., Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B., Rønnov‐Jessen, D., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018017673 · Cited by 13
“Chemosensitive (CR/PR) 703 (97) 345 (94) 358 (98) 183 (96) 99 (96) 84 (97) Nonchemosensitive (NC/PD) 19 (3) 15 (4) 4 (1) 7 (4) 11 (4) 9 (3) Missing 11 (1) 9 (2) 2 (1) NS 0 0 0 NS”
MethodInfluentialBowen, E. M., Pfeiffer, R. M., Linet, M. S., Liu, W. T., Weisenburger, D. D., Freedman, D. M., & Cahoon, E. K. (2016) · British Journal of Cancer · doi:10.1038/bjc.2015.383 · Cited by 13
“Relationship between ambient ultraviolet radiation and Hodgkin lymphoma subtypes in the United States”
Self-citationLinabery, A. M., Prizment, A. E., Anderson, K. E., Cerhan, J. R., Poynter, J. N., & Ross, J. A. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0423 · Cited by 14
Self-citationSolans, M., Benavente, Y., Sáez, M., Agudo, A., Jakszyn, P. G., Naudin, S., Hosnijeh, F. S., Gunter, M. J., Huybrechts, I., Ferrari, P., et al. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-01947-0 · Cited by 12
Zhong, C., Gragert, L. A., Maiers, M. J., Hill, B. T., Garcia-Gomez, J. F., Gendzekhadze, K., Senitzer, D., Song, J. Y., Weisenburger, D. D., Goldstein, L., et al. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1617858 · Cited by 12
“A total of 1977 patients with histologically confirmed NHL per Interlymph/WHO classification [29,30] and 15,020 donors were identified between January 1995 and October 2015.”
BackgroundSelf-citationRacial differences in chronic lymphocytic leukemia
Flowers, C. R., & Pro, B. (2013) · Cancer · doi:10.1002/cncr.28233 · Cited by 12
“Changes in the World Health Organization classification of lymphoid malignancies over the time period studied also could potentially complicate the adjudication of diagnoses across eras.(2,7)”
BackgroundAssociation of Obesity and Type 2 Diabetes with Non-Hodgkin Lymphoma: The Multiethnic Cohort
Maskarinec, G., Brown, S., Lee, J., Bogumil, D. D., Walsh, C. P., Haiman, C. A., Setiawan, V. W., Shvetsov, Y. B., & Marchand, L. L. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-0565 · Cited by 11
Espinosa, A., Zock, J., Benavente, Y., Boffetta, P., Becker, N., Brennan, P., Cocco, P., Foretová, L., Maynadié, M., Staines, A. S., et al. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2013.02.006 · Cited by 11
“eu whether lifetime occupational exposure to HMW agents capable of inducing IgEmediated allergic sensitization is associated with the risk of specific lymphoma subtypes ([17]), aiming to reduce with this analysis the potential effect of a reverse causality mechanism.”
BackgroundSelf-citationCardiovascular mortality trends in non-Hodgkin’s lymphoma: a population-based cohort study
Kamel, M. G., El‐Qushayri, A. E., Thach, T. Q., & Huy, N. T. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1409626 · Cited by 11
“miological research based on the 2008 WHO classification [35] and the third edition of the International Classification of Diseases for Oncology coding system [36].”
MethodAntinuclear Antibodies Are Associated with an Increased Risk of Diffuse Large B-Cell Lymphoma
Frost, E., Hofmann, J. N., Huang, W., Parks, C. G., Frazer‐Abel, A. A., Deane, K. D., & Berndt, S. I. (2023) · Cancers · doi:10.3390/cancers15215231 · Cited by 10
Ermann, D. A., Vardell, V. A., Kallam, A., Silberstein, P. T., & Armitage, J. O. (2019) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2019.11.012 · Cited by 10
Epstein‐Barr virus prevalence among subtypes of malignant lymphoma in Rwanda, 2012 to 2018
Mpunga, T., Clifford, G. M., Morgan, E. A., Milner, D. A., de Martel, C., Munyanshongore, C., Muvugabigwi, G., & Combes, J. (2021) · International Journal of Cancer · doi:10.1002/ijc.33840 · Cited by 10
Aspirin and Other Nonsteroidal Anti-Inflammatory Drugs and Risk of Non-Hodgkin Lymphoma
Teras, L. R., Gapstur, S. M., Patel, A. V., Thun, M. J., Diver, W. R., Zhai, Y., & Jacobs, E. J. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1158 · Cited by 10
Adzersen, K. H., Friedrich, S., & Becker, N. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-2017-z · Cited by 9
Aya‐Bonilla, C., Camilleri, E. T., Haupt, L. M., Lea, R. A., Gandhi, M. K., & Griffiths, L. R. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-390 · Cited by 9
Gao, Y., Li, Q., Bassig, B. A., Chang, E. T., Dai, M., Qin, Q., Zhang, Y., & Zheng, T. (2013) · Cancer Causes & Control · doi:10.1007/s10552-012-0136-2 · Cited by 8
“It is important to note that the etiologies of HL and NHL, which itself comprises dozens of heterogeneous lymphoma subtypes, are distinct [33], and that an association with one lymphoma type does not imply that other lymphomas are also associated with a given risk factor.”
BackgroundA prospective analysis of blood donation history and risk of non-Hodgkin lymphoma
Ishii, K., Birmann, B. M., Zhang, X., Giovannucci, E. L., & Bertrand, K. A. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1091928 · Cited by 9
“Major histologic subtypes of NHL were determined according to the World Health Organization (WHO) classification of lymphomas [15] based on morphology and immunophenotype information available in medical records and the pathology report and consistent with recent International Lymphoma Epidemiology (InterLymph) Consor…”
MethodWadé, N. B., Chang, C. M., Conti, D. V., Millstein, J., Skibola, C. F., Nieters, A., WANG, S. S., de Sanjosé, S., Kane, E. V., Spinelli, J. J., et al. (2020) · Cancer Causes & Control · doi:10.1007/s10552-020-01266-4 · Cited by 8
MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients
Ni, Y., Yin, G., Xiao, Z., Fan, L., Wang, L., Wu, Y., Wu, H., Qian, S., Xu, W., Li, J., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3930-0 · Cited by 8
Jones, S. J., Stroshein, S., Williams, A. M., Liu, D., Spinelli, J. J., Connors, J. M., & Brooks-Wilson, A. R. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1204 · Cited by 7
“Cancers were classified according to the InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research (27).”
Method(2023) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2023.03.001 · Cited by 7
“[1] Turner JJ, Morton LM, Linet MS, et al.”
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS
WANG, S. S., Vajdic, C. M., Linet, M. S., Slager, S. L., Voutsinas, J. M., Nieters, A., Casabonne, D., Cerhan, J. R., Cozen, W., Alarcón, G. S., et al. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0875 · Cited by 7
Self-citationPrediagnostic Serum Tocopherol Levels and the Risk of Non-Hodgkin Lymphoma: The Multiethnic Cohort
Morimoto, Y., Ollberding, N. J., Cooney, R. V., Wilkens, L. R., Franke, A. A., Marchand, L. L., Goodman, M. T., Hernandez, B. Y., Kolonel, L. N., & Maskarinec, G. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0522 · Cited by 7
“Third Edition (ICD-O-3), and aggregated into subtypes in accordance with the proposed hierarchical classification of lymphoid neoplasms for epidemiologic research (25).”
BackgroundMethodSuthandiram, S., Gan, G. G., Zain, S. M., Haerian, B. S., Bee, P. C., Lian, L. H., Chang, K. M., Ong, T. C., & Mohamed, Z. (2014) · Journal of Human Genetics · doi:10.1038/jhg.2014.19 · Cited by 7
Rotating Nightshift Work and Hematopoietic Cancer Risk in US Female Nurses
Zhang, Y., Birmann, B. M., Papantoniou, K., Zhou, E. S., Erber, A. C., & Schernhammer, E. S. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz106 · Cited by 7
“For diagnoses in very early years with no available immunophenotyping information, we used the proposed translation from previous classification systems to the current WHO standard (38,40).”
MethodKorat, A. V. A., Chiu, Y., Bertrand, K. A., Zhang, S., Epstein, M. M., ROSNER, B. A., Chiuve, S. E., Campos, H., Giovannucci, E. L., Chavarro, J. E., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa251 · Cited by 7
“Histologic subtypes were determined according to the WHO classification of lymphomas and categorized as recommended by the International Lymphoma Epidemiology (InterLymph) Consortium Pathology Working Group (22, 23), as described previously (24).”
MethodBesson, C., Moore, A. L., Wu, W., Vajdic, C. M., de Sanjosé, S., Camp, N. J., Smedby, K. E. E., Shanafelt, T. D., Morton, L. M., Brewer, J. D., et al. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab042 · Cited by 7
Self-citationGalicia, N., Dégano, R. M., Díez, P., González‐González, M., Góngora, R., Ibarrola, N., & Fuentes, M. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1307106 · Cited by 7
Hirabayashi, M., Georges, D., Combes, J., & Clifford, G. M. (2026) · International Journal of Cancer · doi:10.1002/ijc.70468 · Cited by 6
“The hierarchy was based on the InterLymph hierarchical classification of lymphoid neoplasm and the 2008 WHO classification of lymphoid neoplasms [13, 14].”
Jaquet, A., Boni, S. P., Boidy, K., Tine, J. M., Tchounga, B., Touré, S. A., Koffi, J. J., Dial, C. M. M., Monnereau, A., Diomandé, I., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33709 · Cited by 6
Self-citationPlasma Cell-Rich Acute Rejection With Monoclonal Gammopathy in a Renal Transplant Recipient
Sun, I. O., Cho, Y. H., Hong, Y. A., Chung, B. H., Choi, B. S., Park, G. S., Choi, Y. J., Park, C. W., Kim, Y. S., & Yang, C. W. (2013) · Experimental and Clinical Transplantation · doi:10.6002/ect.2012.0141 · Cited by 6
Jayasekara, H., Juneja, S. K., Hodge, A. M., Room, R., Milne, R. L., Hopper, J. L., English, D. R., Giles, G. G., & MacInnis, R. J. (2017) · International Journal of Cancer · doi:10.1002/ijc.31123 · Cited by 6
The association of gene rearrangement and lymphoma diagnosis
He, X., Xu, P., Wang, X., Jiang, S., Gong, D., & Wu, N. (2020) · Medicine · doi:10.1097/md.0000000000020733 · Cited by 6
Parental Age and Risk of Lymphoid Neoplasms
Larfors, G., Glimelius, I. C., Eloranta, S., & Smedby, K. E. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx185 · Cited by 6
Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis
Cerhan, J. R., Kane, E. V., Vajdic, C. M., Linet, M. S., Monnereau, A., Bernstein, L., de Sanjosé, S., Chiu, B. C. ‐., Spinelli, J. J., Maso, L. D., et al. (2019) · Cancer Causes & Control · doi:10.1007/s10552-019-01188-w · Cited by 6
Self-citationLeukemia, Lymphoma, and Multiple Myeloma Mortality in the Russian Mayak Worker Cohort 1948–2015
Эдуардович, С. М., Stram, D. O., Preston, D. L., Фаридовна, С. С., Tsareva, Y., Moroz, B. E., & Kuznetsova, I. S. (2025) · Radiation Research · doi:10.1667/rade-23-00059.1 · Cited by 5
Ralli, S., Jones, S. J., Leach, S. R., Lynch, H. T., & Brooks-Wilson, A. R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287602 · Cited by 4
“The type and subtype of the cancers were classified according to the hierarchical classification provided by the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group [2].”
BackgroundMethodSoydinc, H. O., Guney, N., Başaran, M., Duranyıldız, D., & Yasasever, V. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15038590 · Cited by 5
Bassig, B. A., Shu, X., Friesen, M. C., Vermeulen, R. C. H., Purdue, M. P., Ji, B., Yang, G., Wong, J. Y. Y., Appel, N., Hu, W., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.35095 · Cited by 4
Epidemic of Non-Hodgkin Lymphoma in New Zealand Remains Unexplained
Cox, B., Liu, C.-W., Sneyd, M. J., & Cameron, C. (2014) · Journal of Cancer Epidemiology · doi:10.1155/2014/315378 · Cited by 4
Liang, Y., Ding, L., Li, X., Wang, W., & Zhang, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.5583 · Cited by 4
“…primarily in Africa, which usually affects children and adolescents, and is associated with Epstein-Barr virus (EBV) infection; ii) the adult sporadic form; and iii) the immunodeficiency-associated form, occurring primarily in patients infected with the human immunodeficiency virus (HIV) (1,2).”
InfluentialMahale, P. S., Engels, E. A., Lynch, C. F., & Morton, L. M. (2019) · British Journal of Haematology · doi:10.1111/bjh.15828 · Cited by 4
Self-citationThe Clinical Significance of Both IgM and IgG Anticardiolipin Antibodies in Non-Hodgkin’s Lymphoma
Saber, M. M. (2016) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000436 · Cited by 3
“Introduction Non-Hodgkin lymphoma (NHL) is a histologically, etiologically, and clinically heterogeneous group of malignant diseases of the lymphocytes [1].”
BackgroundEpidemiology of Aggressive Lymphomas
Cerhan, J. R. (2018) · Essentials · doi:10.1007/978-3-030-00362-3_1 · Cited by 3
Self-citationDehydroxymethylepoxyquinomicin selectively ablates T-CAEBV cells.
Zhang, H., Yang, W.-T., Wang, Z., Yao, C.-M., Wang, X.-F., Tian, Z.-Q., Jin, Y.-Y., Wang, L.-L., & Chen, T.-X. (2015) · Frontiers in Bioscience · doi:10.2741/4322 · Cited by 4
Using the primary site as a prognostic tool for nodal mantle cell lymphoma: a SEER-based study
Kamel, M. G., El‐Qushayri, A. E., Sayed, A. K., & Huy, N. T. (2020) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2020-0083 · Cited by 3
Samiee, F., Mohammadi, R., Shirian, S., Alijani, M., Aledavood, A., Negahban, S., Ghaemi, A., Daneshbod, K., & Daneshbod, Y. (2021) · Future Oncology · doi:10.2217/fon-2020-0534 · Cited by 3
van Krieken, J. H. (2009) · Journal of Hematopathology · doi:10.1007/s12308-009-0027-y · Cited by 3
“The 2007 InterLymph system is now updated and can indeed serve as such [15].”
New brain lesions in a patient with sarcoidosis: is it neurosarcoidosis?
Pandey, S., Mukhopadhyay, S., Iannuzzi, M. C., & Sah, B. P. (2014) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 3
Muniesa, C., & Hernández‐Machín, B. (2013) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2013.01.003 · Cited by 3
Chen, J., Hart, J. E., VoPham, T., Elliott, E. G., Jones, R. R., Ward, M. H., Laden, F., & Birmann, B. M. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.139115 · Cited by 2
Serum lipid levels and risk of lymphoid malignancies in the UK Biobank study
Hermosa, S., Benavente, Y., Cabezudo, M.-E., Sáinz, J., Farràs, M., Alemany, L., Birmann, B. M., & Casabonne, D. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03196-x · Cited by 2
Agossou, S., Tual, S., Gac, A., Bureau, M., Perrier, S., Mussard, D., Monnereau, A., Baldi, I., & Lebailly, P. (2025) · Environment International · doi:10.1016/j.envint.2025.110024 · Cited by 2
Self-citationKorat, A. V. A., Chiu, Y., Bertrand, K. A., Zhang, S., Epstein, M. M., ROSNER, B. A., Chiuve, S. E., Campos, H., Giovannucci, E. L., Chavarro, J. E., et al. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2022.2131419 · Cited by 2
“We assigned NHL histologic subtype according to the most current (gold standard) World Health Organization (WHO) classification [1] and categorized them for analysis as recommended by the International Lymphoma Epidemiology (InterLymph) Consortium Pathology Working Group [34,35].”
MethodMuniesa, C., & Hernández‐Machín, B. (2013) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2013.01.004 · Cited by 2
Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience
Kim, H. M., Yang, W. I., Lyu, C. J., Hahn, S. M., & Yoon, S. O. (2020) · Yonsei Medical Journal · doi:10.3349/ymj.2020.61.9.774 · Cited by 2
Anticipation in multiple-case lymphoid cancer families after controlling for ascertainment biases
Jones, S. J., & Brooks-Wilson, A. R. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1948026 · Cited by 2
Metadata
- Authors
- Turner, J. J., Morton, L. M., Linet, M. S., Clarke, C. A., Kadin, M. E., Vajdic, C. M., Monnereau, A., Maynadié, M., Chiu, B. C.-H., Marcos-Gragera, R., Costantini, A. S., Cerhan, J. R., & Weisenburger, D. D.
- Affiliations
- Douglass Hanly Moir Pathology (AU)
- National Institutes of Health (US)
- Cancer Prevention Institute of California (US)
- Boston University (US)
- UNSW Sydney (AU)
- Inserm (FR)
- Université de Bourgogne (FR)
- University of Chicago (US)
- Epidemiology Unit, Cancer Registry of Girona, Oncology Planning, Department of Health, Institute of Biomedical Investigation, Girona, Spain;
- Cancer Research and Prevention Institute Epidemiology, Florence, Italy;
- Mayo Clinic (US)
- University of Nebraska Medical Center (US)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2010-11-18
- Volume
- 116
- Issue
- 20
- Pages
- e90-e98
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC2993636
- OpenAlex
- W2070728536
- Cited by
- 231
- References
- 45
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 19 · 2019: 11 · 2018: 15 · 2017: 7 · 2016: 18 · 2015: 25 · 2014: 39 · 2013: 25 · 2012: 16
- FWCI
- 10.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health (CA97274)
- National Cancer Institute (CA97274, R01 CA97274, R01CA092153, P50CA097274)
- National Center for Research Resources (P20RR018757)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Hematology › Hematological disorders and diagnostics
- Keywords
- lymphoid malignancies, hierarchical classification, lymphoma epidemiology, lymphoma subtypes, primary cutaneous T-cell lymphoma
- MeSH terms
- Humans, Lymphoma, Societies, Medical, World Health Organization, Epidemiologic Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
